Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MBX · NASDAQ · Pharmaceutical Preparations
$49.55−3.86 (−7.23%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Mbx Biosciences (MBX) · oqro.io/stocks/MBX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 10, 2026 · Filed Nov 12, 2026
CEO sold ~$268K of MBX shares in the open marketSourcePlanned sale · Planned for Nov 10, 2026 · Notice filed Nov 10, 2026
Director filed to sell about $268K of MBX stockSourceInsider trade · Traded Nov 4, 2026 · Filed Nov 5, 2026
Officer sold ~$20K of MBX shares in the open marketSourcePlanned sale · Planned for Nov 4, 2026 · Notice filed Nov 4, 2026
Officer filed to sell about $20K of MBX stockSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Paradigm Biocapital Advisors LP disclosed a new position in MBX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed a reduced position in MBX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP disclosed a reduced position in MBX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Eventide Asset Management, LLC disclosed a reduced position in MBX for Q2 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed a reduced position in MBX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed a reduced position in MBX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Driehaus Capital Management LLC disclosed a reduced position in MBX for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Longaeva Partners L.P. no longer reported MBX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Orbimed Advisors LLC disclosed a reduced position in MBX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Driehaus Capital Management LLC disclosed a reduced position in MBX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Eventide Asset Management, LLC disclosed a new position in MBX for Q4 2025Fund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Longaeva Partners L.P. disclosed a new position in MBX for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Frazier Life Sciences Management, L.P. disclosed an increased position in MBX for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deep Track Capital, LP disclosed an increased position in MBX for Q3 2025SourceInsider trade · Traded Sep 26, 2025 · Filed Sep 30, 2025
Director purchased ~$12M of MBX shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deep Track Capital, LP disclosed a reduced position in MBX for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Orbimed Advisors LLC disclosed an increased position in MBX for Q1 2025SourceInsider trade · Traded Apr 8, 2025 · Filed Apr 10, 2025
Director purchased ~$45K of MBX shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 19, 2025
Director purchased ~$1.02M of MBX shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 19, 2025
Director purchased ~$1.02M of MBX shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 19, 2025
Director purchased ~$532K of MBX shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 19, 2025
Director purchased ~$532K of MBX shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 15, 2024
Frazier Life Sciences Management, L.P. disclosed a new position in MBX for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Deep Track Capital, LP disclosed a new position in MBX for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Soros Fund Management disclosed a new position in MBX for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Orbimed Advisors LLC disclosed a new position in MBX for Q3 2024Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Driehaus Capital Management LLC disclosed an increased position in MBX for Q2 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Deep Track Capital, LP disclosed an increased position in MBX for Q4 2025SourceInsider trade · Traded Feb 14, 2025 · Filed Feb 19, 2025
Director purchased ~$291K of MBX shares in the open marketSourceInsider trade · Traded Feb 14, 2025 · Filed Feb 19, 2025
Director purchased ~$291K of MBX shares in the open marketSourceInsider trade · Traded Feb 14, 2025 · Filed Feb 19, 2025
Director purchased ~$178K of MBX shares in the open marketSourceInsider trade · Traded Feb 14, 2025 · Filed Feb 19, 2025
Director purchased ~$178K of MBX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Soros Fund Management no longer reported MBX for Q4 2024SourceInsider trade · Traded Feb 4, 2025 · Filed Feb 5, 2025
CEO purchased ~$535K of MBX shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Ra Capital Management, L.P. disclosed a new position in MBX for Q3 2024Source